Kisqali 400 MG daily dose 42S
Ended Awarded
- Contract number
- SPE2DB25FP8P8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,249.98 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Kisqali 400 mg daily dose tablets (42-count units). This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by August 14, 2025, with fulfillment at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio with DLA encompasses a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This delivery order for Kisqali, a oncology medication, reflects AmerisourceBergen's continued role as a primary pharmaceutical supplier supporting Defense Health Agency and broader federal healthcare requirements through the comprehensive global pharmaceutical support vehicle.
Quick answers
Who was awarded contract SPE2DB25FP8P8?
SPE2DB25FP8P8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FP8P8 worth?
The government has obligated $16,250 on SPE2DB25FP8P8.
Is contract SPE2DB25FP8P8 an order under another contract?
Yes. SPE2DB25FP8P8 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FP8P8 competed?
The extent of competition for SPE2DB25FP8P8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award